(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer

Clinical trial NCT00673205 · COMPLETED

Trial details

NCT number: NCT00673205
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Metastatic Prostate Cancer

Start date: 1995-09-01
Primary completion: 2008-08-01
Enrollment: 3588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.